These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25462350)

  • 21. Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2.
    Kong WS; Irie T; Yoshida A; Kawabata R; Kadoi T; Sakaguchi T
    Hiroshima J Med Sci; 2012 Sep; 61(3):59-67. PubMed ID: 23077864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Budding capability of the influenza virus neuraminidase can be modulated by tetherin.
    Yondola MA; Fernandes F; Belicha-Villanueva A; Uccelini M; Gao Q; Carter C; Palese P
    J Virol; 2011 Mar; 85(6):2480-91. PubMed ID: 21209114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza virus partially counteracts restriction imposed by tetherin/BST-2.
    Mangeat B; Cavagliotti L; Lehmann M; Gers-Huber G; Kaur I; Thomas Y; Kaiser L; Piguet V
    J Biol Chem; 2012 Jun; 287(26):22015-29. PubMed ID: 22493439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?
    Andrew A; Strebel K
    J Interferon Cytokine Res; 2011 Jan; 31(1):137-44. PubMed ID: 21166593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BST2/tetherin inhibition of alphavirus exit.
    Ooi YS; Dubé M; Kielian M
    Viruses; 2015 Apr; 7(4):2147-67. PubMed ID: 25912717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of determinants in filovirus glycoproteins required for tetherin antagonism.
    Gnirß K; Fiedler M; Krämer-Kühl A; Bolduan S; Mittler E; Becker S; Schindler M; Pöhlmann S
    Viruses; 2014 Apr; 6(4):1654-71. PubMed ID: 24721789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of Tetherin Inhibition of Alphavirus Release.
    Wan JJ; Ooi YS; Kielian M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Lassa and Marburg virus production by tetherin.
    Sakuma T; Noda T; Urata S; Kawaoka Y; Yasuda J
    J Virol; 2009 Mar; 83(5):2382-5. PubMed ID: 19091864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release.
    Stewart H; Palmulli R; Johansen KH; McGovern N; Shehata OM; Carnell GW; Jackson HK; Lee JS; Brown JC; Burgoyne T; Heeney JL; Okkenhaug K; Firth AE; Peden AA; Edgar JR
    EMBO Rep; 2023 Dec; 24(12):e57224. PubMed ID: 37818801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetherin is as tetherin does.
    Hammonds J; Spearman P
    Cell; 2009 Oct; 139(3):456-7. PubMed ID: 19879831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression.
    Cheshenko N; Trepanier JB; Stefanidou M; Buckley N; Gonzalez P; Jacobs W; Herold BC
    FASEB J; 2013 Jul; 27(7):2584-99. PubMed ID: 23507869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists.
    Hagelauer E; Lotke R; Kmiec D; Hu D; Hohner M; Stopper S; Nchioua R; Kirchhoff F; Sauter D; Schindler M
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
    Weidner JM; Jiang D; Pan XB; Chang J; Block TM; Guo JT
    J Virol; 2010 Dec; 84(24):12646-57. PubMed ID: 20943977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural insight into the mechanisms of enveloped virus tethering by tetherin.
    Yang H; Wang J; Jia X; McNatt MW; Zang T; Pan B; Meng W; Wang HW; Bieniasz PD; Xiong Y
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18428-32. PubMed ID: 20940320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular evolution of the primate antiviral restriction factor tetherin.
    Liu J; Chen K; Wang JH; Zhang C
    PLoS One; 2010 Jul; 5(7):e11904. PubMed ID: 20689591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent loss events of a functional
    Krchlíková V; Lotke R; Haußmann I; Reinišová M; Kučerová D; Pecnová Ľ; Ungrová L; Hejnar J; Sauter D; Elleder D
    J Virol; 2023 Oct; 97(10):e0080323. PubMed ID: 37712707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity to BST-2 restriction correlates with Orthobunyavirus host range.
    Varela M; Piras IM; Mullan C; Shi X; Tilston-Lunel NL; Pinto RM; Taggart A; Welch SR; Neil SJD; Kreher F; Elliott RM; Palmarini M
    Virology; 2017 Sep; 509():121-130. PubMed ID: 28628828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetherin antagonism by V proteins is a common trait among the genus Rubulavirus.
    Ohta K; Matsumoto Y; Ito M; Nishio M
    Med Microbiol Immunol; 2017 Aug; 206(4):319-326. PubMed ID: 28466381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo.
    Barrett BS; Smith DS; Li SX; Guo K; Hasenkrug KJ; Santiago ML
    PLoS Pathog; 2012; 8(3):e1002596. PubMed ID: 22457621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons.
    Sarojini S; Theofanis T; Reiss CS
    DNA Cell Biol; 2011 Dec; 30(12):965-74. PubMed ID: 21919738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.